About Our Company Our History Our Mission, Vision, Values Our Leadership
Integrity Contact
Investors Overview News Events Letters to Stockholders Corporate Governance SEC Filings & Financials Stock Information Investor Resources
Integrity Contact

“It takes vision to build an eyecare business that ensures patient access to affordable sight-saving medications. That promise – of access and affordability – is the Harrow foundation; it’s our guiding principle and what drives our actions as a responsible corporate citizen.”

Mark L. Baum, April 2021

Mark L. Baum

“The drug business is the only business in the world where drugs that are really old and should be really inexpensive ...are not,” stated Harrow Health CEO Mark Baum in late 2016 as he made the closing argument at the debate entitled, "Big Pharma Prioritizes Profits Over Patients" at the world-famous Oxford Union Society. This concern for patient access to affordable medication led, two years earlier, to the founding of Harrow Health, and the application of "outside-the-box" thinking and a deep commitment to 360 degree pharmaceutical value chain innovation to address unmet patient needs while offering a solution for rising or unaffordable drug prices.

With 16+ million(1) dry eye patients in the U.S., 3+ million(2) glaucoma patients and 8+ million(3) annual ophthalmic surgeries, the market need for improved access and lower cost is enormous. In addition, as the U.S. population ages, the healthy impact of Harrow’s platform on patients, families and communities will continue to grow.

(1) Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol 2017;182:90-8.
(2) According to Glaucoma Research Foundation: https://www.glaucoma.org/about/fast-facts-glaucoma-research-foundation.php.
(3) According to a 2019 report by Marketscope, a third-party provider of market data.

Doing Good

Our business was established in response to certain parts of the pharmaceutical industry that too often pursued profits at the expense of people – and around a fundamental understanding that such a model was too often both ethically indefensible and ultimately unsustainable.

We live out our commitment to putting people first in ways that go well beyond our transformative approach to making medications more affordable to those who need them.

We live out that mission around the globe with U.S. ophthalmologists by contributing to both local and international missions and indigent programs to patients in need each year. Watch the video of our recent mission trips in Honduras, Sierra Leone, Grenada, and Kenya, to name a few. These missions have provided medicines that would otherwise not be available and have assisted doctors in giving back the gift of sight to countless patients.

We support our local community through charitable action. Since moving to Nashville, Tennessee, in late 2019, Harrow’s small but mighty team provided Christmas gifts through a local “Angel Tree,” donated 220 pounds of food to local families through Second Harvest Food Bank of Middle Tennessee, and sponsored a clothing drive supporting the Nashville Rescue Mission’s homeless shelter. Harrow employees are currently planning additional regular charitable events.

Angel Tree
Angel Tree
Second Harvest Food Bank
of Middle Tennessee
Nashville Rescue Mission Homeless Shelter Drive